This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Learn when to mix SP 500 and bond funds in retirement to balance risk and growth. This brief guide covers practical timing rules to help you stay on track.
28,655 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
A controversial proposal has sparked a fierce debate among developers, miners, and industry leaders. This article unp...
When markets swing downward, the smartest move is often to buy quality that pays you to wait. Here are three dividend...
The latest update on the darrell sheets toxicology report adds new public detail to a high-profile case. This piece b...
A fresh institutional stake in PENN Entertainment signals shifting sentiment in a dynamic gaming landscape. This deep...
Investors woke up to a surprising move in CoreWeave stock Monday. The rally hinges on a trail of AI hardware mileston...
ACV Auctions delivered strong fourth-quarter numbers and a hopeful 2026 outlook, but shares plunged as investors weig...
Pi Network’s co-founder reveals new KYC milestones and a plan to offer KYC as a service, signaling a major shift for ...
Alphabet’s latest AI and cloud initiatives are fueling optimism, even as investors weigh whether Wall Street is under...
OpenAI is renegotiating its Pentagon deal to block domestic surveillance, with new safeguards and agency restrictions...
A former Ball State staffer will receive $225,000 to settle a First Amendment lawsuit after the university fired her ...
Defense-tech pioneer Palmer Luckey calls for public-oversight over AI, arguing government power should guide how AI i...